Vanda Pharmaceuticals
VNDA
#7815
Rank
โ‚ฌ0.28 B
Marketcap
4,87ย โ‚ฌ
Share price
-5.57%
Change (1 day)
17.24%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -โ‚ฌ0.11 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ0.21 Billion. In 2024 the company made an earning of -โ‚ฌ34.37 Million a decrease over its 2023 earnings that were of -โ‚ฌ11.8 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ0.11 Billion211.67%
2024 -โ‚ฌ34.37 Million191.43%
2023 -โ‚ฌ11.8 Million-320.45%
2022 โ‚ฌ5.34 M-84.99%
2021 โ‚ฌ35.64 M54.8%
2020 โ‚ฌ23.02 M19.42%
2019 โ‚ฌ19.28 M4.93%
2018 โ‚ฌ18.37 M-228.6%
2017 -โ‚ฌ14.29 Million-8.98%
2016 -โ‚ฌ15.7 Million-53.79%
2015 -โ‚ฌ33.97 Million-30.18%
2014 -โ‚ฌ48.66 Million173.08%
2013 -โ‚ฌ17.82 Million-25.33%
2012 -โ‚ฌ23.86 Million163.61%
2011 -โ‚ฌ9.06 Million-221.15%
2010 โ‚ฌ7.47 M-124.53%
2009 -โ‚ฌ30.46 Million-29.44%
2008 -โ‚ฌ43.17 Million-36.2%
2007 -โ‚ฌ67.66 Million21.81%
2006 -โ‚ฌ55.55 Million170.55%
2005 -โ‚ฌ20.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ27.38 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.82 B-13,603.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ10.01 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ19.02 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ19.51 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.79 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚ฌ2.38 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA